BRIEF published on 12/13/2024 at 12:05, 1 year 10 months ago BlackRock crosses holding thresholds at RUBIS Voting Rights Capital BlackRock Ruby Detention Thresholds
PRESS RELEASE published on 12/13/2024 at 12:00, 1 year 10 months ago Franchissement de seuils Déclaration de franchissement de seuils par BlackRock, Inc. pour la société RUBIS sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils BlackRock Inc. RUBIS
BRIEF published on 12/09/2024 at 09:40, 1 year 10 months ago Franchissement de seuils par BlackRock dans RUBIS Droits De Vote Franchissement De Seuils BlackRock RUBIS Actions En Collatéral
BRIEF published on 12/09/2024 at 09:40, 1 year 10 months ago BlackRock Crosses Thresholds in RUBIS Voting Rights BlackRock Crossing Thresholds Ruby Collateral Actions
PRESS RELEASE published on 12/09/2024 at 09:35, 1 year 10 months ago Franchissement de seuils Déclaration de franchissement de seuils pour l'acquisition de actions de la société RUBIS par BlackRock, Inc. pour le compte de clients et de fonds. Augmentation due au collatéral Actions Franchissement De Seuils BlackRock Collatéral RUBIS
BRIEF published on 10/07/2024 at 07:35, 2 years ago Rubis lance un programme de rachat d'actions Rachat D'actions Réglementation Marché Dilution RUBIS
BRIEF published on 10/07/2024 at 07:35, 2 years ago Rubis launches share buyback program Share Buyback Regulation Dilution Ruby Walk
PRESS RELEASE published on 10/07/2024 at 07:30, 2 years ago Rubis: Programme de rachat d'actions Rubis lance un programme de rachat d'actions pour annuler des actions et contrôler la dilution. Le programme durera jusqu'au 29 novembre 2024 avec un maximum de 1 000 000 actions Rachat D'actions Dilution Programme RUBIS Contrôle
PRESS RELEASE published on 10/07/2024 at 07:30, 2 years ago Rubis: Share buyback programme Rubis Management Board launches share buyback program to control dilution from share issues. Programme to purchase up to 1,000,000 shares at €50 per share, ending on 29 Nov 2024 Stock Options Share Buyback Market Abuse RUBIS Dilution Control
BRIEF published on 09/17/2024 at 07:05, 2 years 1 month ago Rubis Sets Ambitious Targets at Photosol Day 2024 Solar Energy RUBIS Photosol Renewable Growth Photovoltaic Markets
Published on 10/19/2026 at 14:30, 4 hours 10 minutes ago Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 4 hours 40 minutes ago Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 5 hours 10 minutes ago Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 5 hours 10 minutes ago Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 5 hours 39 minutes ago CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Published on 10/19/2026 at 18:05, 35 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 55 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:45, 55 minutes ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Published on 10/19/2026 at 17:30, 1 hour 10 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 19/10/2026
Published on 10/19/2026 at 17:30, 1 hour 10 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/19/2026 (French only)
Published on 10/19/2026 at 18:00, 40 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 40 minutes ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
Published on 10/19/2026 at 17:45, 55 minutes ago Déclaration des transactions sur actions propres réalisées du 12 au 16 octobre 2026 dans le cadre du programme de rachat d’actions
